Business Context and Reporting Period
This Form 6-K filing by Baird Medical Investment Holdings Ltd covers the period of November 2024. The report is issued to disclose a material change in corporate governance regarding the resignation of the Chief Financial Officer and Company Secretary.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding personnel changes and contains no financial performance data.
Material Changes
- Resignation: Mr. Kun Seng Ng resigned from the positions of Chief Financial Officer and Company Secretary effective November 1, 2024.
- Reason: The resignation was for personal reasons and did not result from any disagreement with the Company regarding operations, policies, or practices.
- Succession: Ms. Jie Li has been appointed as the acting Chief Financial Officer effective November 1, 2024.
Management Commentary and Risks
Management confirmed that the departure of Mr. Ng was amicable. Ms. Li, who has served as the Company's reporting director since May 2024, brings extensive experience from "Big Four" PRC-based accounting firms and over five years of experience in U.S. listed companies managing financial reporting and internal controls. No specific risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition (November 1, 2024).
- Confirm that the resignation was not related to any operational or policy disagreements.
- Review Ms. Jie Li's qualifications and tenure as reporting director to assess continuity in financial oversight.